| S.No | PRODUCT | CAS NO | STRUCTURE | THERAPEUTIC APPLICATION | |
|---|---|---|---|---|---|
| 1 | ACEBUTOLOL | 37517-30-9 |  |
Antiarrhythmics (Beta blockers) (Group II); Beta-adrenergic blocking agents :cardioselective beta blockers;Beta-adrenoceptor agonists (beta1-agonists) also known as ADRB1, is a beta-adrenergic receptor Agonists | |
| 2 | ACETAZOLAMIDE | 59-66-5 |  | Diuretics (Carbonic anhydrase inhibitors) | |
| 3 | ADENOSINE | 58-61-7 |  | Adenosine receptor modulator agonists; Antiarrhythmics (Group V) | |
| 4 | ALFUZOSIN | 81403-80-7 |  | Alpha-adrenoceptor blockers (alpha-blockers) | |
| 5 | ALISKIREN | 173334-57-1 |  | Renin inhibitors | |
| 6 | ALPROSTADIL | 745-65-3 |  | Direct-acting Vasodilators | |
| 7 | AMBRISENTAN | 177036-94-1 |  | Endothelin receptor antagonists | |
| 8 | AMILORIDE HYDROCHLORIDE | 2016-88-8 |  | Diuretics (Potassium-sparing diuretics) | |
| 9 | AMIODARONE | 1951-25-3 |  | Antiarrhythmics: Potassium-channel blockers (Group III) | |
| 10 | AMLODIPINE | 88150-42-9 |  | Antiarrhythmics: Calcium-channel blockers (Group IV) | |
| 11 | APADENOSON | 250386-15-3 |  | Selective A2a adenosine receptor agonist | |
| 12 | ATENOLOL | 29122-68-7 |  | Cardioselective beta blockers; Beta-adrenoceptor agonists (beta1-agonists) also known as ADRB1, is a beta-adrenergic receptor | |
| 13 | ATROPINE | 51-55-8 |  | Muscarinic receptor antagonists; Anticholinergic chronotropic agents ( also known as muscarinic antagonists or parasympatholytic)Positive chronotropes | |
| 14 | ATORVASTATIN | 134523-00-5 |  | HMG-CoA reductase inhibitors | |
| 15 | AZILSARTAN | 147403-03-0 |  | Angiotensin receptor blockers (also called ARBs or angiotensin II inhibitors) | |
| 16 | BENAZEPRIL | 86541-75-5 |  | Angiotensin-converting enzyme inhibitors (ACE inhibitors) | |
| 17 | BETAXOLOL | 63659-18-7 |  | Beta-adrenergic blocking agents (cardioselective beta blockers) ; Beta-adrenoceptor agonists (beta1-agonists) also known as ADRB1, is a beta-adrenergic receptor | |
| 18 | BINODENOSON | 144348-08-3 |  | Adenosine receptor modulator agonist | |
| 19 | BISOPROLOL | 66722-44-9 |  | Beta-adrenergic blocking agents (cardioselective beta blockers); Beta-adrenoceptor agonists (beta1-agonists) also known as ADRB1, is a beta-adrenergic receptor | |
| 20 | BOSENTAN | 147536-97-8 |  | Endothelin receptor antagonists | |
| 21 | BRINZOLAMIDE | 138890-62-7 |  | Diuretics (Carbonic anhydrase inhibitors) | |
| 22 | BUFALIN | 465-21-4 |  | Cardiac glycosides (Na+-K+- ATPase pump inhibitors) | |
| 23 | BUMETANIDE | 28395-03-1 |  | Diuretics (loop) | |
| 24 | CANAGLIFLOZIN | 842133-18-0 |  | Sodium-glucose co-transporter 2 (SGLT-2) inhibitors | |
| 25 | CANDESARTAN | 139481-59-7 |  | Angiotensin receptor blocker (ARBs or angiotensin II inhibitor) | |
| 26 | CAPADENOSON | 544417-40-5 |  | Selective adenosine A1‐receptor agonist | |
| 27 | CAPTOPRIL | 62571-86-2 |  | Angiotensin-converting enzyme inhibitors (ACE inhibitors) | |
| 28 | CARVEDILOL | 72956-09-3 |  | Non-selective β-adrenergic receptor antagonist (β1, β2) and an α-adrenergic receptor antagonist (α1) | |
| 29 | CHLORISONDAMINE | 7701-62-4 |  | Ganglionic blockers | |
| 30 | CHLORTHALIDONE | 77-36-1 |  | Diuretics (thiazide) | |
| 31 | CILOSTAZOL | 73963-72-1 |  | Peripheral vasodilators | |
| 32 | CINOBUFAGIN | 470-37-1 |  | Cardiac glycosides (Na+-K+- ATPase pump inhibitors) | |
| 33 | CLONIDINE | 4205-90-7 |  | Centrally acting antiadrenergic agents (sympatholytic) | |
| 34 | CLOPIDOGREL | 113665-84-2 |  | Cardiovascular agent | |
| 35 | CONIVAPTAN | 210101-16-9 |  | Vasopressin antagonists | |
| 36 | CROMAKALIM | 94470-67-4 |  | Potassium-channel openers | |
| 37 | DABIGATRAN | 211915-06-9 |  | Fibrinolytic (thrombolytic) | |
| 38 | DAPAGLIFLOZIN | 461432-26-8 |  | Sodium-glucose co-transporter 2 (SGLT-2) inhibitors | |
| 39 | DENOPAMINE | 71771-90-9 |  | Beta-adrenoceptor agonists (beta1-agonists) also known as ADRB1, is a beta-adrenergic receptor | |
| 40 | DIAZOXIDE | 364-98-7 |  | Potassium-channel openers | |
| 41 | DICLOFENAMIDE | 120-97-8 |  | Diuretics (Carbonic anhydrase inhibitors) | |
| 42 | DILTIAZEM | 42399-41-7 |  | Antiarrhythmics: Calcium-channel blockers (Group IV) | |
| 43 | DISOPYRAMIDE | 3737-09-5 |  | Antiarrhythmics: Sodium-channel blockers (Group 1); (late sodium currents) | |
| 44 | DOBUTAMINE | 34368-04-2 |  | Sympathomimetics; Vasopressors; Inotropic agents; Beta-adrenoceptor agonists (beta1-agonists) also known as ADRB1, is a beta-adrenergic receptor; Catecholamines | |
| 45 | DOFETILIDE | 115256-11-6 |  | Antiarrhythmics: Potassium-channel blockers (Group III) | |
| 46 | DORZOLAMIDE | 120279-96-1 |  | Diuretics (Carbonic anhydrase inhibitors) | |
| 47 | DOXAZOSIN | 74191-85-8 |  | Alpha-adrenoceptor blockers (alpha-blockers) | |
| 48 | DRONEDARONE | 141626-36-0 |  | Antiarrhythmics: Potassium-channel blockers (Group III) | |
| 49 | EMPAGLIFLOZIN | 864070-44-0 |  | Sodium-glucose co-transporter 2 (SGLT-2) inhibitors | |
| 50 | ENALAPRIL | 75847-73-3 |  | Angiotensin-converting enzyme inhibitors (ACE inhibitors) | |
| 51 | ENCAINIDE | 66778-36-7 |  | Sodium-channel blocker (late sodium currents) | |
| 52 | EPHEDRINE | 299-42-3 |  | Vasopressors | |
| 53 | EPINEPHRINE | 51-43-4 |  | Vasopressors; Sympathomimetics; Anticholinergic chronotropic agents ( also known as muscarinic antagonists or parasympatholytic) Positive chronotropes; Catecholamines | |
| 54 | EPLERENONE | 107724-20-9 |  | Aldosterone receptor antagonists (ARAs) (also called an antimineralocorticoid, MCRA, and sometimes MRA); Diuretics (potassium-sparing) | |
| 55 | EPROSARTAN | 133040-01-4 |  | Angiotensin receptor blockers (also called ARBs or angiotensin II inhibitors) | |
| 56 | ERTUGLIFLOZIN | 1210344-57-2 |  | Sodium-glucose co-transporter 2 (SGLT-2) inhibitors | |
| 57 | ESMOLOL | 81147-92-4 |  | Beta-adrenergic blocking agents (cardioselective beta blockers); Antiarrhythmics (Beta blockers) (Group II) | |
| 58 | ETHACRYNIC ACID | 58-54-8 |  | Diuretic agent (loop) | |
| 59 | ETHANOLAMINE OLEATE | 2272-11-9 |  | Sclerosing agents | |
| 60 | ETHOXZOLAMIDE | 452-35-7 |  | Diuretics (Carbonic anhydrase inhibitors) | |
| 61 | FINERENONE | 1050477-31-0 |  | Funny current blockers; Aldosterone receptor antagonists (ARAs) (also called an antimineralocorticoid, MCRA, and sometimes MRA); | |
| 62 | FLECAINIDE | 54143-55-4 |  | Sodium-channel blocker (late sodium currents) | |
| 63 | FLUPIRTINE | 56995-20-1 |  | Potassium-channel openers | |
| 64 | FLUVASTATIN | 93957-54-1 |  | HMG-CoA reductase inhibitors | |
| 65 | FOSINOPRIL | 98048-97-6 |  | Angiotensin-converting enzyme inhibitors (ACE inhibitors) | |
| 66 | FUROSEMIDE | 54-31-9 |  | Diuretic agent (loop) | |
| 67 | GABAPENTIN | 60142-96-3 |  | HCN channel Blockers | |
| 68 | GUANABENZ | 5051-62-7 |  | Centrally acting antiadrenergic agents (sympatholytic) | |
| 69 | GUANFACINE | 29110-47-2 |  | Centrally acting antiadrenergic agents (sympatholytic) | |
| 70 | HEXAMETHONIUM | 60-26-4 |  | Ganglionic blockers | |
| 71 | HYDRALAZINE | 86-54-4 |  | Nitrodilators; Direct-acting Vasodilators | |
| 72 | HYDROCHLOROTHIAZIDE | 58-93-5 |  | Diuretics (thiazide) | |
| 73 | IBUTILIDE | 122647-31-8 |  | Antiarrhythmics: Potassium-channel blockers (Group III) | |
| 74 | INDAPAMIDE | 26807-65-8 |  | Diuretics (thiazide) | |
| 75 | IRBESARTAN | 138402-11-6 |  | Angiotensin receptor blockers (also called ARBs or angiotensin II inhibitors) | |
| 76 | ISOPROTERENOL | 7683-59-2 |  | Vasopressors; Sympathomimetics; Anticholinergic chronotropic agents ( also known as muscarinic antagonists or parasympatholytic) Positive chronotropes; Catecholamines | |
| 77 | ISORDIL | 87-33-2 |  | Nitrodilators | |
| 78 | ISOSORBIDE MONONITRATE | 16051-77-7 |  | Antianginal agents | |
| 79 | ISOTRATE | 652-67-5 |  | Nitrodilators | |
| 80 | IVABRADINE | 155974-00-8 |  | HCN channel blockers; Funny current blockers | |
| 81 | LABETALOL | 36894-69-6 |  | Beta-adrenergic blocking agents | |
| 82 | LIDOCAINE | 137-58-6 |  | Antiarrhythmics: Sodium-channel blockers (Group 1) (late sodium currents); | |
| 83 | (S)-LISINOPRIL DIHYDRATE | 83915-83-7 |  | Angiotensin-converting enzyme inhibitors (ACE inhibitors) | |
| 84 | LOFEXIDINE | 31036-80-3 |  | Centrally acting antiadrenergic agents (sympatholytic) | |
| 85 | LOSARTAN | 114798-26-4 |  | Angiotensin receptor blockers (also called ARBs or angiotensin II inhibitors) | |
| 86 | LOVASTATIN | 75330-75-5 |  | HMG-CoA reductase inhibitors | |
| 87 | MACITENTAN | 441798-33-0 |  | Endothelin receptor antagonists | |
| 88 | MAVACAMTEN | 1642288-47-8 |  | Cardiovascular agent | |
| 89 | MEXILETINE | 31828-71-4 |  | Antiarrhythmics: Sodium-channel blockers (Group 1); (late sodium currents) | |
| 90 | METOPROLOL | 51384-51-1 |  | Cardioselective beta blockers; Beta-adrenoceptor agonists (beta1-agonists) also known as ADRB1, is a beta-adrenergic receptor; Funny current blockers | |
| 91 | METHAZOLAMIDE | 554-57-4 |  | Diuretics (Carbonic anhydrase inhibitors) | |
| 92 | METOLAZONE | 17560-51-9 |  | Diuretics (thiazide) | |
| 93 | METHYCLOTHIAZIDE | 135-07-9 |  | Diuretics (thiazide) | |
| 94 | MECAMYLAMINE | 6147-18-8 |  | Ganglionic blockers | |
| 95 | MILRINONE | 78415-72-2 |  | Anticholinergic chronotropic agents ( also known as muscarinic antagonists or parasympatholytic)Positive chronotropes; Inotropic agents | |
| 96 | MINOXIDIL | 38304-91-5 |  | Potassium-channel openers; Direct-acting Vasodilators | |
| 97 | MOEXIPRIL | 103775-10-6 |  | Angiotensin-converting enzyme inhibitors (ACE inhibitors) | |
| 98 | MORICIZINE | 31883-05-3 |  | Antiarrhythmics: Sodium-channel blockers (Group 1); (late sodium currents) | |
| 99 | MOXISYLYTE | 54-32-0 |  | Peripheral vasodilators | |
| 100 | NADOLOL | 42200-33-9 |  | Beta-adrenergic blocking agents | |
| 101 | NAFTIDROFURYL | 31329-57-4 |  | Peripheral vasodilators | |
| 102 | NEBIVOLOL | 118457-14-0 |  | Cardioselective beta blockers; Beta-adrenoceptor agonists (beta1-agonists) also known as ADRB1, is a beta-adrenergic receptor | |
| 103 | NELADENOSON BIALANATE | 1239309-58-0 |  | Adenosine receptor modulator agonists | |
| 104 | NERIIFOLIN | 466-07-9 |  | Cardiac glycosides (Na+-K+- ATPase pump inhibitors) | |
| 105 | NICORANDIL | 65141-46-0 |  | Potassium-channel openers | |
| 106 | NIFEDIPINE | 21829-25-4 |  | Peripheral vasodilators | |
| 107 | NITROGLYCERIN | 55-63-0 |  | Antianginal agents; Direct-acting Vasodilators | |
| 108 | NORADRENALINE | 51-41-2 |  | Beta-adrenoceptor agonists | |
| 109 | OLEANDRIN | 465-16-7 |  | Cardiac glycosides (Na+-K+- ATPase pump inhibitors) | |
| 110 | OLMESARTAN MEDOXOMIL | 144689-63-4 |  | Angiotensin receptor blockers (also called ARBs or angiotensin II inhibitors) | |
| 111 | OMECAMTIV MECARBIL | 873697-71-3 |  | Funny current blockers | |
| 112 | ORVATEN | 42794-76-3 |  | Cardiovascular agent | |
| 113 | OUABAIN | 630-60-4 |  | Cardiac glycosides (Na+-K+- ATPase pump inhibitors) | |
| 114 | PEIMISINE | 19773-24-1 |  | Muscarinic receptor antagonists | |
| 115 | PEMPIDINE | 79-55-0 |  | Ganglionic blockers | |
| 116 | PENBUTOLOL | 38363-40-5 |  | Beta-adrenergic blocking agents | |
| 117 | PENTOLINIUM | 144-44-5 |  | Ganglionic blockers | |
| 118 | PENTOXIFYLLINE | 6493-05-6 |  | Peripheral vasodilators | |
| 119 | PERINDOPRIL | 82834-16-0 |  | Angiotensin-converting enzyme inhibitors (ACE inhibitors) | |
| 120 | PINACIDIL | 60560-33-0 |  | Nonselective beta blocker | |
| 121 | PINDOLOL | 13523-86-9 |  | Beta-adrenergic blocking agents | |
| 122 | PITAVASTATIN | 147511-69-1 |  | HMG-CoA reductase inhibitors | |
| 123 | PHENYLEPHRINE | 59-42-7 |  | Vasopressors | |
| 124 | PHENYTOIN | 57-41-0 |  | Antiarrhythmics: Sodium-channel blockers (Group 1) (late sodium currents) | |
| 125 | PHLORIZIN | 60-81-1 |  | Cardiac glycosides (Na+-K+- ATPase pump inhibitors) | |
| 126 | PRAVASTATIN | 81093-37-0 |  | HMG-CoA reductase inhibitors | |
| 127 | PRAZOSIN | 19216-56-9 |  | Alpha-adrenoceptor blockers (alpha-blockers) | |
| 128 | PROCAINAMIDE | 51-06-9 |  | Antiarrhythmics: Sodium-channel blockers (Group 1) (late sodium currents) | |
| 129 | PROPAFENONE | 54063-53-5 |  | Antiarrhythmics: Sodium-channel blockers (Group 1) (late sodium currents) | |
| 130 | PROPRANOLOL | 525-66-6 |  | Antiarrhythmics (Beta blockers) (Group II); Beta-adrenergic blocking agents | |
| 131 | QUINAPRIL | 85441-61-8 |  | Angiotensin-converting enzyme inhibitors (ACE inhibitors) | |
| 132 | QUINIDINE | 56-54-2 |  | Antiarrhythmics: Sodium-channel blockers (Group 1) (late sodium currents) | |
| 133 | RAMIPRIL | 87333-19-5 |  | Angiotensin-converting enzyme inhibitors (ACE inhibitors) | |
| 134 | RANOLAZINE | 95635-55-5 |  | Antianginal agents | |
| 135 | REGADENOSON | 313348-27-5 |  | Adenosine receptor modulator agonists | |
| 136 | REMIKIREN | 126222-34-2 |  | Renin inhibitors | |
| 137 | RETIGABINE | 150812-12-7 |  | Potassium-channel openers | |
| 138 | RIOCIGUAT | 625115-55-1 |  | Direct-acting vasodilators | |
| 139 | ROSUVASTATIN | 287714-41-4 |  | HMG-CoA reductase inhibitors | |
| 140 | SACUBITRIL | 149709-62-6 |  | Neprilysin inhibitors (ARNI) | |
| 141 | SARPOGRELATE | 125926-17-2 |  | Muscarinic receptor antagonists | |
| 142 | SILDENAFIL | 139755-83-2 |  | Phosphodiesterase inhibitors | |
| 143 | SILODOSIN | 160970-54-7 |  | Alpha adrenoreceptor antagonists (Selective α1-adrenergic receptor antagonists) | |
| 144 | SIMVASTATIN | 79902-63-9 |  | HMG-CoA reductase inhibitors | |
| 145 | SITAXSENTAN | 184036-34-8 |  | Endothelin receptor antagonists | |
| 146 | SODIUM TETRADECYL SULFATE | 139-88-8 |  | Sclerosing agents | |
| 147 | SOTALOL | 3930-20-9 |  | Antiarrhythmics: Potassium-channel blockers (Group III); Beta-adrenergic blocking agents | |
| 148 | SPIRONOLACTONE | 52-01-7 |  | Aldosterone receptor antagonists (ARAs) (also called an antimineralocorticoid, MCRA, and sometimes MRA); Potassium-sparing diuretics | |
| 149 | TADANAFIL | 171596-29-5 |  | Phosphodiesterase inhibitors | |
| 150 | TAMSULOSIN | 106133-20-4 |  | Alpha adrenoreceptor antagonists(Selective α1-adrenergic receptor antagonists) | |
| 151 | TELMISARTAN | 144701-48-4 |  | Angiotensin receptor blockers (also called ARBs or angiotensin II inhibitors) | |
| 152 | TERAZOSIN | 63590-64-7 |  | Alpha-adrenoceptor blockers (alpha-blockers) | |
| 153 | THEOPHYLLINE | 58-55-9 |  | Anticholinergic chronotropic agents ( also known as muscarinic antagonists or parasympatholytic) Positive chronotropes | |
| 154 | TIMOLOL | 26839-75-8 |  | Beta-adrenergic blocking agents | |
| 155 | TOCAINIDE | 41708-72-9 |  | Antiarrhythmics: Sodium-channel blockers (Group 1), (late sodium currents) | |
| 156 | TOLVAPTAN | 150683-30-0 |  | Vasopressin antagonists | |
| 157 | TORSEMIDE | 56211-40-6 |  | Diuretics (loop) | |
| 158 | TRANDOLAPRIL | 87679-37-6 |  | Angiotensin-converting enzyme inhibitors (ACE inhibitors) | |
| 159 | TRIAMTERENE | 396-01-0 |  | Diuretics (Potassium-sparing) | |
| 160 | TRIMETAPHAN CAMSILATE | 68-91-7 |  | Ganglionic blockers | |
| 161 | VALSARTAN | 137862-53-4 |  | Angiotensin receptor blockers (also called ARBs or angiotensin II inhibitors); Neprilysin inhibitors (ARNI) | |
| 162 | VARDENAFIL | 224785-90-4 |  | Phosphodiesterase inhibitors | |
| 163 | VERAPAMIL | 52-53-9 |  | Antiarrhythmics; Calcium-channel blockers (Group IV) | |
| 164 | VERICIGUAT | 1350653-20-1 |  | Direct-acting vasodilators; Funny current blocker | |
| 165 | VORTIOXETINE | 508233-74-7 |  | Beta-adrenoceptor antagonists (as beta blockers) | |
| 166 | XAMOTEROL | 81801-12-9 |  | Beta-adrenoceptor agonists (beta1-agonists) also known as ADRB1, is a beta-adrenergic receptor | |
| 167 | YM758 | 312752-86-6 |  | Funny current blockers | |
| 168 | ZD-7288 | 133059-99-1 |  | HCN channel blockers | |
| 169 | ZONISAMIDE | 68291-97-4 |  | Diuretics (Carbonic anhydrase inhibitors) |
Note : Our company provides building blocks, key intermediates, and impurities associated with the above products, but not active pharmaceutical ingredients (APIs).
Disclaimer: Building blocks, key intermediates, and impurities associated with the above products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.
